General Practice Future
General practice is truly at a crossroads. It is facing many pressures and challenges but also opportunities. The expectations for
health care are changing from all points of view, including patients, policymakers, the NHS and GPs themselves. There is no shortage of analysis. It is knowing what to do next that matters.
Some people have expressed uncertainty about the future of general practice. Choices have to be made about the direction of
health policy. There are those who believe that the profession does not have solutions to the problems that the
health system is facing. The College believes that they are wrong.
This document – the product of intense deliberation and discussion – offers a vision for better patient care in the NHS. The RCGP believes that it is essential for GPs to put forward their own ideas for improving patient care. Sometimes we are so busy in our active day-to-day clinical work that it is hard to step back and consider strategic issues. But this is precisely what we have to do.
This Roadmap can be used to challenge policymakers, and to support
business cases for the development of services that build on the values we espouse here.
The status quo is not sustainable. Fragmentation of care,
health inequalities and urgent care must be addressed. Furthermore, if we are to meet the
health needs of patients over the coming years, we will need to bring about a radical change in the quality, organisation and delivery of services.
High Impact List of Articles
-
Understanding the role of resveratrol in major neurological and lifestyle diseases: an insight into molecular mechanisms and
druggability
Amarendranath Choudhury, Rudrarup Bhattacharjee, Dattatreya Adapa, Indrajeet Chakraborty, Tuhin Subhra Banerjee, Dhilleshwara Rao Vana
Research Article: Pharmaceutical Bioprocessing
-
Understanding the role of resveratrol in major neurological and lifestyle diseases: an insight into molecular mechanisms and
druggability
Amarendranath Choudhury, Rudrarup Bhattacharjee, Dattatreya Adapa, Indrajeet Chakraborty, Tuhin Subhra Banerjee, Dhilleshwara Rao Vana
Research Article: Pharmaceutical Bioprocessing
-
Synthesis and x-ray crystallographic studies of azatricyclo-sulfonamide derivatives
Lakshminarayanan Karthik, Jagadeesan Ganapathy, Pennathur Gautam & Gunasekaran Krishnasamy*
Research Article: Pharmaceutical Bioprocessing
-
Synthesis and x-ray crystallographic studies of azatricyclo-sulfonamide derivatives
Lakshminarayanan Karthik, Jagadeesan Ganapathy, Pennathur Gautam & Gunasekaran Krishnasamy*
Research Article: Pharmaceutical Bioprocessing
-
Analytical models for biopharmaceutical operations and supply chain management
Philip Kaminsky* and Yang Wang
Review Article: Pharmaceutical Bioprocessing
-
Analytical models for biopharmaceutical operations and supply chain management
Philip Kaminsky* and Yang Wang
Review Article: Pharmaceutical Bioprocessing
-
Optimizing Chinese hamster ovary cell line development via targeted control of N-glycosylation
Christina S Alves* and Shashi Prajapati
Review Article: Pharmaceutical Bioprocessing
-
Optimizing Chinese hamster ovary cell line development via targeted control of N-glycosylation
Christina S Alves* and Shashi Prajapati
Review Article: Pharmaceutical Bioprocessing
-
High-throughput screening and automation approaches for the development of recombinant therapeutic proteins
Gregory Keil*
Review Article: Pharmaceutical Bioprocessing
-
High-throughput screening and automation approaches for the development of recombinant therapeutic proteins
Gregory Keil*
Review Article: Pharmaceutical Bioprocessing
-
Single-use perfusion bioreactors support continuous biomanufacturing
William (Bill) G Whitford
Review Article: Pharmaceutical Bioprocessing
-
Single-use perfusion bioreactors support continuous biomanufacturing
William (Bill) G Whitford
Review Article: Pharmaceutical Bioprocessing
-
Recombinant protein and mAb biopharmaceuticals to become a commodity?
Emile van Corven*
Editorial: Pharmaceutical Bioprocessing
-
Recombinant protein and mAb biopharmaceuticals to become a commodity?
Emile van Corven*
Editorial: Pharmaceutical Bioprocessing
-
Report on 10th Annual bioProcess UK Conference
Ajoy Velayudhan* and Andrew Davidson
Conference Report: Pharmaceutical Bioprocessing
-
Report on 10th Annual bioProcess UK Conference
Ajoy Velayudhan* and Andrew Davidson
Conference Report: Pharmaceutical Bioprocessing
-
Antibody Drug conjugates: the success of failure
Uwe Gottschalk
Editorial: Pharmaceutical Bioprocessing
-
Antibody Drug conjugates: the success of failure
Uwe Gottschalk
Editorial: Pharmaceutical Bioprocessing
-
Considerations in upstream bioprocess
monitoring and statistical data analysis
in the
context of process analytical technology and
quality by design
Gerald Striedner & Karl Bayer
Review Article: Pharmaceutical Bioprocessing
-
Considerations in upstream bioprocess
monitoring and statistical data analysis
in the
context of process analytical technology and
quality by design
Gerald Striedner & Karl Bayer
Review Article: Pharmaceutical Bioprocessing
Relevant Topics in Clinical